Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN06
- Pharmacological subgroupN06A
- Chemical subgroupN06AA
- Chemical substanceN06AA02Imipramine
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 9 medicines
SFDA · 4 medicines · Historical list
AEMPS · 3 medicines
PHARMAC · 3 medicines
HSA · 2 medicines
TFDA · 2 medicines
CBG-MEB · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
9 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Imipramine Pamoate | United States | 100MG HYDROCHLORIDE, 125MG HYDROCHLORIDE, 150MG HYDROCHLORIDE … | capsule | Marketed | Rising |
| Imipramine Hydrochloride | United States | 10MG, 25MG, 50MG | tablet | Marketed | Roxane |
| Imipramine Hydrochloride | United States | 25MG/ML | concentrate | Not marketed | Novartis |
| Pramine | United States | 10MG, 25MG, 50MG | tablet | Not marketed | Alra |
| Janimine | United States | 10MG, 25MG, 50MG | tablet | Not marketed | Abbott |
| Presamine | United States | 10MG, 25MG, 50MG | tablet | Not marketed | Sanofi Aventis US |
| Tofranil | United States | 12.5MG/ML | injectable | Not marketed | Novartis |
| Tofranil | United States | 50MG | tablet | Not marketed | Specgx LLC |
| Tofranil-PM | United States | 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effect | capsule | Not marketed | Specgx LLC |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, Anvisa, CBG-MEB, FDA, Health Canada, HSA, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.